Growth Equity
Growth Credit
Healthcare
Contact
Menu
Investor Log in
Close
Growth Equity
Growth Credit
Healthcare
Contact
About Us
Team
Careers
Insights
Portfolio
Investors
Home
/
Insights
/
Hatchtech publish data on Head Lice treatment safety study and mechanism of action
Hatchtech publish data on Head Lice treatment safety study and mechanism of action
27 November 2012
Posted in —
OneVentures
Share
Linkedin
Twitter
Copy Link
Learn More
Share
Linkedin
Twitter
Copy Link
You may also like
02 August 2020
OneVentures
FDA Approves Xeglyze™ for the topical treatment of head lice infestation
02 August 2020
OneVentures
Hatchtech gets lice treatment nod from FDA
01 February 2018
OneVentures
No nit picking: Head lice group Hatchtech gets green light to trials
View All
Ventured. Gained.